Skip to main content

Genito-Crural Island Perforator Flap (GCIPF) for Vulvar Reconstruction

The genito-crural island perforator flap (GCIPF) is a fasciocutaneous island flap harvested near the genitocrural (labiocrural / genitofemoral) sulcus. Its individual perforator and pedicle must be identified during planning and surgery; adjacent aOAP and internal-pudendal flap literature does not prove that every GCIPF uses the same source vessel. In the Toulouse group's single-center, retrospective 27-patient/46-flap series, no total flap necrosis was reported, median hospitalization was 4 days, and 78.3% were reported to achieve complete vulvar healing within four weeks. These are selected-cohort observations, not a comparison establishing first-line superiority.[1][2][3]

For the broader treatment menu see the Vulvar Reconstruction Atlas. For related parent / sibling flaps see the foundations Lotus Petal, Singapore / pudendal-thigh, IGAP / Gluteal-Fold, IPAP, and SCIP pages.


Anatomic Basis and Nomenclature​

The genitocrural sulcus (sulcus genitofemoralis / labiocrural fold) is the natural crease between the vulva and the medial thigh — ideal as a donor site because of its thin, pliable tissue immediately adjacent to the vulva.[3][4]

The GCIPF can be considered alongside several historically described flaps from nearby anatomic territories, without treating their pedicles or outcomes as interchangeable:

Related flapFirst describedRelationship to GCIPF
Pudendal-thigh (Singapore)Wee & Joseph 1989Original axial-pattern flap from the genitocrural region[4]
Lotus petalYii & Niranjan 1996Genitocrural sulcus = "upper petal" of the lotus design[4]
Anterior obturator artery perforator (aOAP)O'Dey 2010Related sulcus vascular territory; not proof that the GCIPF cohort used an aOAP pedicle in every case[3]
IPAP flapHashimoto 2014Distinct internal-pudendal perforator source in the broader perineal territory[5]
Perineal perforator switch flap (PPSF)Shin 2022Tunneled island perforator flap around perforators close to the genitofemoral sulcus[6]

The Toulouse name describes the flap location and island design. O'Dey's aOAP, Hashimoto's IPAP and Shin's perineal switch flap are useful adjacent concepts, but their distinct pedicle anatomy and outcomes must not be merged with Commenge's GCIPF cohort without the original operative maps.[1][3][5][6]


Vascular Anatomy​

  • The sulcus genitofemoralis is supplied by a perforator from the anterior branch of the obturator artery with its accompanying vein.
  • The aOAP was identified in 20/20 specimens in this cadaveric sample; this does not guarantee the vessel or usable flap territory in every patient.
  • Two perforator types:
    • Musculocutaneous (80%, 16/20) — pierces the gracilis muscle.
    • Septocutaneous (20%, 4/20) — passes the posterior border of the gracilis.
  • Perforator location: 1.3 ± 0.3 cm lateral to the inferior pubic ramus.
  • aOAP skin territory: ~7 × 15 cm centered on the sulcus genitofemoralis.

Contributing supply (Höckel 2008)[4]​

SourceTerritory
External pudendal aa. (superficial / deep)Anterior / upper perineal
Internal pudendal a. perforatorsMedial / posterior
Obturator a. perforatorsLateral (dominant per O'Dey)
Medial circumflex femoral a.Medial thigh

These sources can contribute to regional vascularity, but a specific flap survives on its preserved pedicle; an adjacent vascular network does not remove the need to verify that pedicle after prior surgery or radiation.

Sensory innervation​

  • Perineal branches of the pudendal nerve — primary supply to the medial portion.[7]
  • Ilioinguinal and genitofemoral nerves — contribute to the anterior / upper territory.
  • Some island-flap designs can preserve cutaneous innervation, but sensibility after GCIPF specifically was not quantified in Commenge's abstract; do not promise a sensate flap.[4][7]

Indications​

IndicationDetail
HemivulvectomyUnilateral GCIPF[1]
Radical / total vulvectomyBilateral GCIPF (19/27 patients in Commenge bilateral)[1]
Vulvar squamous cell carcinomaPrimary indication
Extramammary Paget diseaseAssess defect after oncologic resection; no disease-specific GCIPF outcome is established by the indexed abstract
Vulvar melanomaAssess margins and available tissue; no disease-specific GCIPF outcome established here
Vulvar dysplasia / VINIncluded in the publisher's indexed study methods, but subgroup outcomes need the full article

The authors call it a routine option within their tertiary center. Their indexed results describe 27/128 vulvectomies (21.1%) using at least one GCIPF, with primary closure in 61.7% and another flap used in 22 patients; this is not first-line use for all vulvar defects.[1]


Surgical Technique — general island-perforator principles[1][3][6]​

The following sequence preserves practical planning concepts, but Commenge's complete operative text and figures were not available for this source pass. It must not be read as a verified, fixed GCIPF protocol.

  1. Position — lithotomy.
  2. Design — island skin paddle along the genitocrural sulcus / labiocrural fold, centered over the perforator, sized to the defect.
  3. Perforator identification — map a usable patient-specific perforator. O'Dey's ~1.3-cm landmark describes the aOAP cadaveric sample, not a guaranteed GCIPF point.[3]
  4. Incision and elevation — circumferential incision; raised as a true island flap on its perforator pedicle, preserving the soft tissue around the pedicle.
  5. Transfer — transpose or tunnel only if the pedicle reaches without compression or torsion. O'Dey describes a tunneled aOAP variant with a concealed scar; its aesthetic claim is not a direct GCIPF comparative result.[3]
  6. Inset — sutured with attention to 3D vulvar-contour restoration.
  7. Donor closure — primary, with the scar concealed in the natural labiocrural fold.

Key technical points:

  • Raise unilaterally or bilaterally depending on defect size.[1]
  • Provides thin, pliable tissue closely matching vulvar skin — unlike bulkier musculocutaneous flaps.[3]
  • A tunneled aOAP-type island can conceal the scar in selected anatomy, provided pedicle perfusion and inset are maintained; no universal aesthetic outcome is established.[3]

Outcomes — Commenge et al. (online 2025, print 2026), a 27-patient single-center GCIPF series[1]​

The original abstract reports some percentages without a clear patient-versus-flap denominator; only the explicitly stated patient and flap totals should be treated as fixed denominators until the full tables are read.

ParameterResult
Patients27
Total flaps46 (19 bilateral, 8 unilateral)
Median age61 y (range 35–81)
Median BMI27.7 kg/m² (range 18.7–43.6)
Smokers44.4%
No risk factors for impaired healing59.3% as classified by authors; exact risk-factor definition needs full methods, particularly alongside 44.4% smokers
Total flap necrosis0/46 flaps reported
Complete vulvar healing < 4 wk78.3%
Complete vulvar healing > 8 wk4.3%
Donor-site healing < 4 wk69.6%
Donor-site healing > 8 wk2.2%
Median hospitalization4 d (range 1–15)
Overall complication rate33.3% of patients in the abstract
Wound dehiscence17.4%
Local infection21.7%
Life-threatening complications0%
Delay in adjuvant RTNone reported among those receiving it; treated subgroup denominator not in abstract

Position in the Toulouse Algorithm (2025)[2]​

The Toulouse paper proposes a location-based author algorithm that often favors perforator options when their pedicle and tissue match the defect. Its complete figure and selection table were not accessible in this source pass; this is not a universal guideline or proof of superiority over direct closure or musculocutaneous flaps.

  • GCIPF, IPAP and DFAP are distinct options whose donor territory and defect reach differ.
  • Musculocutaneous flaps are reserved for selected cases when perforator flaps are not feasible.
  • Aim: restore contour and function while preserving oncologic treatment; comparative self-image, sexual-function and cancer outcomes for GCIPF remain unestablished.

FeatureGCIPFIPAPDFAP / PAP
Pedicle sourceConfirm individually; do not equate the GCIPF label with a fixed aOAP pedicleInternal pudendal a.Profunda femoris a.
Donor siteGenitocrural sulcus (labiocrural fold)Ischiorectal fossa / gluteal foldPosteromedial thigh
Tissue thicknessVery thin and pliableThin (can be thinned)Moderate (can be thinned)
Skin territoryPatient-specific; ~7 × 15 cm belongs to O'Dey's aOAP cadaveric description, not a tested GCIPF limit[3]VariableVariable
Reported useSelected internal/lateral vulvar defectsSelected perineal/vulvar defectsSelected lateral/extended defects
Scar locationLabiocrural fold (concealed)Gluteal fold (concealed)Posteromedial thigh (visible)
Flap survivalNo total loss among 46 GCIPFs in one center[1]Depends on a different study populationDepends on a different study population
Wound complications in Han's non-GCIPF 47-patient cohortNot studied12.9% for 31 IPAP patients37.5% for 16 PAP or TUG patients combined (p = 0.04)[9]
[1][3][5][8]

Han et al. (2023) observed fewer wound complications with IPAP (12.9%, n = 31) than the combined PAP/TUG group (37.5%, n = 16; p = 0.04) in a retrospective 47-patient cohort. GCIPF was not tested, and a selected-group comparison does not establish a causal advantage for genitocrural over thigh perforators.[9]


Comparison with Other Vulvar Reconstruction Approaches​

Perforator vs non-perforator flaps (Wendelspiess meta-analysis 2024, n = 1,840)[10]​

  • Overall short-term surgical complication rate comparable between perforator (n = 276) and non-perforator (n = 1,564) flaps (p > 0.05).
  • Tendency toward fewer complications with perforator flaps.
  • QOL assessment scarce across studies.

Pedicled perforator flaps for vulvar reconstruction (Huang 2015, n = 16 / 27 flaps)[8]​

  • Multiple perforator flap types (DFAP, MCFAP, EPAP, IPAP, free-style).
  • All 27 mixed perforator flaps survived in this 16-patient series; this is not a GCIPF result.
  • All donor sites closed primarily; the abstract reported no donor-site morbidity during its observed follow-up.
  • All patients satisfied with cosmetic / functional results (except 1 requiring debulking).
  • The authors proposed thinner fasciocutaneous coverage with favorable outcomes; their series did not directly compare outcomes with musculocutaneous flaps.

Perineal perforator switch flap (Shin 2022, n = 16 / 27 flaps)[6]​

  • Perforators identified close to the genitofemoral sulcus — an adjacent, not necessarily identical, GCIPF territory.
  • Island flap centered on the perforator, tunneled subcutaneously without pedicle skeletonization.
  • 100% flap survival; no major surgical complications.
  • Mean OR time 79.4 ± 19.7 min; hospitalization 5.69 ± 0.79 d.
  • In a nonrandom comparison with the authors' earlier propeller-flap experience, esthetic scores favored PPSF for symmetry (p = 0.015) and labial shape (p = 0.031); not a GCIPF comparison.
  • Did not delay adjuvant RT.

Advantages​

AdvantageDetail
Ideal tissue matchThin, pliable, immediately adjacent to the vulva — closely matches vulvar skin in color / texture / thickness[3]
Concealed donor scarHidden in the labiocrural fold; scars limited within the urogenital region[1][3]
No total flap necrosis0% total flap loss in Commenge (46 flaps)[1]
Rapid healing78.3% complete vulvar healing within 4 wk[1]
Short hospitalizationMedian 4 d (range 1–15)[1]
No reported adjuvant-RT delayObserved only in patients who received adjuvant RT; subgroup size not available in the abstract[1]
Practical nearby donorThe authors characterize their selected-center procedure as simple and reliable; this is their experience, not a comparative guarantee[1]
Related vascular mapaOAP found in 20/20 cadaveric specimens, ~1.3 cm lateral to inferior pubic ramus; GCIPF-specific pedicle reliability not thereby established[3]
No muscle sacrificeFasciocutaneous / perforator design[3][8]
Potential sensory preservationDepends on design and preserved nerve branches; no quantified GCIPF sensory outcome in the original abstract[4][7]
VersatileUnilateral or bilateral; hemivulvectomy through total vulvectomy[1]
Primary donor closureAll donor sites closed primarily[1][8]
May be compatible with selected groin operationsMap the planned dissection and donor pedicle; medial groin extension can compromise available vessels[7]

Limitations​

LimitationDetail
Limited dedicated evidenceCommenge's single-center 27-patient/46-flap series does not establish comparative performance or long-term outcomes[1]
33.3% overall complication rateNo total flap necrosis, but wound dehiscence (17.4%) and local infection (21.7%) common[1]
Limited bulkA thin island alone may not fill post-exenteration dead space; select additional vascularized bulk to match the defect. The cited ~7 × 15-cm territory is aOAP cadaveric anatomy, not a validated GCIPF size ceiling[3][4]
Perforator variabilityO'Dey's aOAP sample had 80% musculocutaneous and 20% septocutaneous course; individual GCIPF pedicle still requires mapping[3]
No long-term QOL dataCommenge reports surgical outcomes only; no validated QOL or sexual-function assessment[1]
Potential conflict with medially extended LNDVascular pedicle at risk if groin dissection extended medially[4]
Lack of comparative studiesNo head-to-head comparison with IPAP, DFAP, V-Y, or lotus-petal for the GCIPF specifically

Key Takeaways​

  1. GCIPF is a thin island-perforator option from the labiocrural fold; its actual pedicle and sensory preservation require individual confirmation.[1][3]
  2. O'Dey's related aOAP map comes from 20 cadaveric specimens; its location and ~7 × 15-cm territory must not be treated as a universal GCIPF specification.[3]
  3. Commenge's 27-patient/46-flap selected series reported no total loss, 78.3% complete vulvar healing within four weeks and median four-day hospitalization; adjuvant RT was not delayed in treated patients.[1]
  4. The Toulouse algorithm is an author-proposed location-based approach, not a guideline or direct superiority trial; in that center 27/128 vulvectomies received a GCIPF.[1][2]
  5. A thin nearby donor and concealed labiocrural scar can be useful when the perforator, reach and defect fit; sensibility and appearance are not guaranteed.[1][3]
  6. The flap cannot fill substantial pelvic dead space alone, and durable GCIPF-specific comparative, functional and oncologic outcomes remain unestablished.[1]

References​

1. Commenge V, Martinez A, Ricotta G, et al. Use of the genito-crural island perforator flap in vulvar reconstruction: a single-center experience. Int J Gynecol Cancer. 2026;36(2):102847 (online December 2025). doi:10.1016/j.ijgc.2025.102847

2. Ricotta G, Russo SA, Ferron G, Meresse T, Martinez A. The Toulouse algorithm: vulvar cancer location-based reconstruction. Int J Gynecol Cancer. 2025;35(4):100065. doi:10.1016/j.ijgc.2024.100065

3. O'Dey DM, Bozkurt A, Pallua N. The anterior obturator artery perforator (aOAP) flap: surgical anatomy and application of a method for vulvar reconstruction. Gynecol Oncol. 2010;119(3):526–530. doi:10.1016/j.ygyno.2010.08.033

4. Höckel M, Dornhöfer N. Vulvovaginal reconstruction for neoplastic disease. Lancet Oncol. 2008;9(6):559–568. doi:10.1016/S1470-2045(08)70147-5

5. Hashimoto I, Abe Y, Nakanishi H. The internal pudendal artery perforator flap: free-style pedicle perforator flaps for vulva, vagina, and buttock reconstruction. Plast Reconstr Surg. 2014;133(4):924–933. doi:10.1097/PRS.0000000000000008

6. Shin J, Kim SA, Rhie JW. Perineal perforator switch flap for three-dimensional vulvovaginal reconstruction. J Plast Reconstr Aesthet Surg. 2022;75(9):3208–3216. doi:10.1016/j.bjps.2022.04.052

7. Moschella F, Cordova A. Innervated island flaps in morphofunctional vulvar reconstruction. Plast Reconstr Surg. 2000;105(5):1649–1657. doi:10.1097/00006534-200004050-00008

8. Huang JJ, Chang NJ, Chou HH, et al. Pedicle perforator flaps for vulvar reconstruction — new generation of less invasive vulvar reconstruction with favorable results. Gynecol Oncol. 2015;137(1):66–72. doi:10.1016/j.ygyno.2015.01.526

9. Han WY, Kim Y, Han HH. A simplified algorithmic approach to vulvar reconstruction according to various types of vulvar defects. Ann Plast Surg. 2023;91(2):270–276. doi:10.1097/SAP.0000000000003597

10. Wendelspiess S, Kouba L, Stoffel J, et al. Perforator versus non-perforator flap-based vulvoperineal reconstruction — a systematic review and meta-analysis. Cancers. 2024;16(12):2213. doi:10.3390/cancers16122213